These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31967019)

  • 1. PHOSPHATURIC MESENCHYMAL HEEL TUMOR PRESENTING WITH TUMOR-INDUCED OSTEOMALACIA.
    Kaur T; Rush ET; Bhattacharya RK
    AACE Clin Case Rep; 2019; 5(2):e138-e141. PubMed ID: 31967019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Induced Osteomalacia Localized and Excised After Pregnancy.
    Sum M; Hoda ST; Rapp T; Zan E
    AACE Clin Case Rep; 2021; 7(6):363-366. PubMed ID: 34765732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
    Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
    Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Phosphate Wasting Due to Tumor-Induced (Oncogenic) Osteomalacia.
    Amaratunga EA; Ernst EB; Kamau J; Kotala R; Snyder R
    Cureus; 2021 Jun; 13(6):e15507. PubMed ID: 34268038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report.
    Gandhi GY; Shah AA; Wu KJ; Gupta V; Shoraka AR
    Case Rep Endocrinol; 2012; 2012():185454. PubMed ID: 23346426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
    Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia.
    Bower RS; Daugherty WP; Giannini C; Parney IF
    Surg Neurol Int; 2012; 3():151. PubMed ID: 23372968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.
    Colazo JM; DeCorte JA; Gillaspie EA; Folpe AL; Dahir KM
    Bone Rep; 2021 Jun; 14():100744. PubMed ID: 33490314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes.
    Zimering MB; Caldarella FA; White KE; Econs MJ
    Endocr Pract; 2005; 11(2):108-14. PubMed ID: 15901526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of phosphaturic mesenchymal tumor-induced osteomalacia.
    Wu W; Wang C; Ruan J; Chen F; Li N; Chen F
    Medicine (Baltimore); 2017 Dec; 96(51):e9470. PubMed ID: 29390586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
    Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
    Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
    Ni HJ; Clifton-Bligh R; Brzozowska MM
    Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
    [No Abstract]   [Full Text] [Related]  

  • 16. Phosphaturic Mesenchymal Tumor in the Proximal Femur Presenting as Tumor-induced Osteomalacia: A Case Report and Literature Review.
    Tungenwar S; Subith S; Mukadam M; Kokate S; Gunay S
    J Orthop Case Rep; 2024 Feb; 14(2):23-28. PubMed ID: 38420233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced osteomalacia: experience from a South American academic center.
    González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
    Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-induced osteomalacia.
    Florenzano P; Gafni RI; Collins MT
    Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of
    Yu HN; Liu L; Chen QS; He Q; Li YS; Wang Y; Gao S
    Orthop Surg; 2021 May; 13(3):791-798. PubMed ID: 33709632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced osteomalacia treated with T12 tumor resection.
    Mancini AJ; Sabet A; Nielsen GP; Parker JA; Schwab JH; Ward A; Wu JS; Malabanan AO
    Endocrinol Diabetes Metab Case Rep; 2022 Dec; 2022():. PubMed ID: 36511458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.